In EBV‐infected NPC cells, the expression of EBV‐encoded LMP1 has been reported to enhance glycolysis by modulating multiple signaling pathways, including those involving FGF1, AMPK, and mTORC1, to drive glucose metabolism (Chen et al, 2010; Ye et al, 2013; Zhang et al, 2017). This evidence concerns the gene FGF1 and nasopharyngeal carcinoma.